PDCD1 and gastric cancer: After undergoing several rounds of treatment, immune checkpoint inhibitors (ICIs) specifically targeting the PD-1/PD-L1 axis have shown great effectiveness in treating advanced gastric cancer that is unresponsive to chemotherapy.